In this NB model, tumor progression leads to an increase of CD4+CD25+FoxP3+ Treg cells, although also CD4+CD25− T cells mediated immune regulatory functions, as the use of anti-CD25 mAb was ineffective20. This evidence concerns the gene CD4 and neuroblastoma.